Hos HIV- inficerede patienter med mild til moderat svækket leverfunktion, er der set en stigning på omkring 30% i lopinavir eksposition, men dette forventes ikke at have nogen klinisk relevans. (se pkt.
In HIV-infected patients with mild to moderate hepatic impairment, an increase of approximately 30% in lopinavir exposure has been observed but is not expected to be of clinical relevance.